Normal human immunoglobulins for intravenous use (IVIg) delay hyperacute xenograft rejection through F(ab')2-mediated anti-complement activity

Ch Latremouille, D. Genevaz, Ming C Hu, O. Schussler, N. Goussef, C. Mandet, P. Bruneval, N. Haeffner-Cavaillon, A. Carpentier, D. Glotz

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Normal human immunoglobulins for intravenous use (IVIg) delay hyperacute xenograft rejection through F(ab')2-mediated anti-complement activity'. Together they form a unique fingerprint.

Medicine & Life Sciences